VERU INC. Deferred Tax Asset, Interest Carryforward
VERU INC. (VERU) had Deferred Tax Asset, Interest Carryforward of $2.22 million as of 2025-09-30, per its 10-K filed 2025-12-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetInterestCarryforward · last filed 2025-12-17
- 2025-09-30: Deferred Tax Asset, Interest Carryforward $2.22M.
- 2024-09-30: Deferred Tax Asset, Interest Carryforward $2.24M.
- 2023-09-30: Deferred Tax Asset, Interest Carryforward $2.60M.
- 2023-06-30: Deferred Tax Asset, Interest Carryforward $2.58M; Deferred Tax Asset, Interest Carryforward as first filed $2.52M.
| Period end | Deferred Tax Asset, Interest Carryforward | Deferred Tax Asset, Interest Carryforward as first filed |
|---|---|---|
| 2025-09-30 | $2.22M 10-K · filed 2025-12-17 | |
| 2024-09-30 | $2.24M 10-K · filed 2025-12-17 | |
| 2023-09-30 | $2.60M 10-K · filed 2024-12-16 | |
| 2023-06-30 | $2.58M 10-Q/A · filed 2023-11-15 | $2.52M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $2.46M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $2.34M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $2.21M 10-K/A · filed 2024-04-01 | |
| 2022-06-30 | $2.12M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.90M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.63M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $1.37M 10-K · filed 2022-12-05 | |
| 2021-06-30 | $1.17M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $706.62K 10-Q · filed 2021-05-12 | |
| 2020-09-30 | $850.25K 10-K · filed 2021-12-02 | |
| 2020-06-30 | $757.14K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $524.85K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $259.92K 10-Q · filed 2020-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |